PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma
Oncology Research · I-Chang Shih, Chung-Yung Ma, Horng-Dar Wang et al. · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma?
- PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma was written by I-Chang Shih, Chung-Yung Ma, Horng-Dar Wang, Chiou-Hwa Yuh.
- When was PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma first published?
- PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma was first published in 2026.
Sources
Last updated · facts checked 9 November 2026
Cite this page
"PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma". DigiNepal. Last updated 9 October 2026. https://diginpl.com/books/paper-or-2026-086574. Retrieved 10 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.086574.